NYSE:GMEDMedical Equipment
A Look At Globus Medical (GMED) Valuation After Recent Analyst Upgrades And Preliminary Q4 Revenue Update
Recent analyst calls around Globus Medical (GMED) have sharpened the market’s focus on the stock, following positive preliminary fourth quarter revenue, commentary on margin expansion, and fresh coverage tied to Nevro, international growth, and enabling technologies.
See our latest analysis for Globus Medical.
The recent upgrade and new coverage come after a period where short term share price momentum has cooled, with a 30 day share price return showing a 4.78% decline. In contrast, the 3...